مقالات در نشریات
- 21. Mansouri, S., Mokhtari , Hesari, P., Naghavi , al , Hosseini, F., (...), Ghahremanlou, M., Farahmand, L.,Evaluating human epidermal growth factor receptor 2 roles in the efficacy of Tamoxifen treatment in breast cancer, a systematic review,Pharmacological Reports,2021.
- 22. Barati, M., Javidi, M.A., Darvishi, B., (...), Farahmand, L., Madjid Ansari, A.,Necroptosis triggered by ROS accumulation and Ca2+ overload, partly explains the inflammatory responses and anti-cancer effects associated with 1Hz, 100 mT ELF-MF in vivo,Free Radical Biology and Medicine,2021.
- 23. Barzaman, K., Samadi, M., Moradi ,& kalbolandi, S., (...), Shekarabi, M., Farahmand, L.,Development of a recombinant anti-VEGFR2-EPCAM bispecific antibody to improve antiangiogenic efficiency,Experimental Cell Research,2021.
- 24. Barzaman, K., Moradi ,& Kalbolandi, S., Hosseinzadeh, A., (...), Safari, E., Farahmand, L.,Breast cancer immunotherapy: Current and novel approaches,International Immunopharmacology,2021.
- 25. Moradi , kalbolandi, S., Majidzadeh , A, K., Abdolvahab, M.H., Jalili, N., Farahmand, L.,The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development,Probiotics and Antimicrobial Proteins,2021.
- 26. Samadi, M., Majidzadeh , A, K., Salehi, M., (...), Moradi , Kalbolandi, S., Farahmand, L.,Engineered hypoxia-responding Escherichia coli carrying cardiac peptide genes, suppresses tumor growth, angiogenesis and metastasis in vivo,Journal of Biological Engineering,2021.
- 27. Merikhian, P., Eisavand, M.R., Farahmand, L.,Triple-negative breast cancer: understanding Wnt signaling in drug resistance,Cancer Cell International,2021.
- 28. Darvishi, B., Boroumandieh, S., Majidzadeh ,& A, K., (...), Jafari, F., Farahmand, L.,The role of activated leukocyte cell adhesion molecule (ALCAM) in cancer progression, invasion, metastasis and recurrence: A novel cancer stem cell marker and tumor-specific prognostic marker,Experimental and Molecular Pathology,2020.
- 29. Abdolvahab, M.H., Darvishi, B., Zarei, M., Majidzadeh ,& A, K., Farahmand, L.,Interferons: Role in cancer therapy,Immunotherapy,2020.
- 30. Rezvani, V., Pourianfar, H.R., Mohammadnejad, S., Madjid Ansari, A., Farahmand, L.,Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms,Applied Microbiology and Biotechnology,2020.
- 31. Rezaei, L., Shojaosadati, S.A., Farahmand, L., Moradi ,& Kalbolandi, S.,Enhancement of extracellular bispecific anti-MUC1 nanobody expression in E. coli BL21 (DE3) by optimization of temperature and carbon sources through an autoinduction condition,Engineering in Life Sciences,2020.
- 32. Barzaman, K., Karami, J., Zarei, Z., (...), Safari, E., Farahmand, L.,Breast cancer: Biology, biomarkers, and treatments,International Immunopharmacology,2020.
- 33. Darvishi, B., Salehi, M., Boroumandieh, S., (...), Moradi ,& Kalbolandi, S., Farahmand, L.,Dual in vitro invasion/migration suppressing and tamoxifen response modulating effects of a recombinant anti-ALCAM scFv on breast cancer cells,Cell Biochemistry and Function,2020.
- 34. Moradi , Kalbolandi, S., Sharifi , K, A., Darvishi, B., (...), Salehi, M., Farahmand, L.,Evaluation the potential of recombinant anti-CD3 nanobody on immunomodulatory function,Molecular Immunology,2020.
- 35. Moradi ,& Kalbolandi, S., Dashtestani, F., Salehi, M., (...), Yadegari, A., Farahmand, L.,Development of an anti-CD45RA-quantum dots conjugated scFv to detect leukemic cancer stem cells,Molecular Biology Reports,2020.
- 36. Mokhtari, H., Farahmand, L., Yaserian, K., Jalili, N., Majidzadeh ,& A, K.,The antiproliferative effects of cold atmospheric plasma-activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism,Journal of Cellular Physiology,2019.
- 37. Yadegari, F., Farahmand, L., Esmaeili, R., Samadi, T., Majidzadeh, K.,Functional investigation of the BRCA1 Val1714Gly and Asp1733Gly variants by computational tools and yeast transcription activation assay,Molecular Biology Research Communications,2019.
- 38. Mansouri, S., Mokhtari , Hesari, P., Naghavi , Al , Hosseini, F., Keivan Majidzadeh, A., Farahmand, L.,The prognostic value of circulating tumor cells in primary breast cancer prior to any systematic therapy: A systematic review,Current Stem Cell Research and Therapy,2019.
- 39. Khatibi, A.S., Roodbari, N.H., Majidzade ,& A, K., Yaghmaei, P., Farahmand, L.,Tumor-suppressing and anti-angiogenic activities of a recombinant anti-CD3ϵ nanobody in breast cancer mice model,Immunotherapy,2019.
- 40. Mahdi, A., Darvishi, B., Majidzadeh ,& A, K., Salehi, M., Farahmand, L.,Challenges facing antiangiogenesis therapy: The significant role of hypoxia-inducible factor and MET in development of resistance to anti-vascular endothelial growth factor-targeted therapies,Journal of Cellular Physiology,2019.
نمایش ۲۱ تا ۴۰ مورد از کل ۷۵ مورد.